<DOC>
	<DOC>NCT01964521</DOC>
	<brief_summary>An open, non-comparative, multi-centre post marketing clinical follow-up, PMCF, investigation to evaluate performance and safety on diabetic foot ulcer, dfu, when using mepilex transfer Ag as intended.</brief_summary>
	<brief_title>TITLE: An Open, Non-comparative, Multi-centre Post Marketing Clinical Follow-up (PMCF) Investigation to Evaluate Performance and Safety on Diabetic Foot Ulcer, DFU, When Using Mepilex Transfer Ag as Intended</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1. Both gender&gt;=18 years old 2. Subjects with type 1 or 2 diabetes mellitus 3. Two of the signs of infection must be present and recorded (redness, heat, oedema, pain, increased exudates amount, deteriorating wound, fever, odour) 4. Ulcer localization; below the ankle 5. Signed Informed Consent 1. Dry wound 2. Known allergy/hypersensitivity to the dressing 3. Treated with other Silver dressing on the ulcer target within 1 week prior to this investigation 4. Subjects who will have problems following the clinical investigation plan 5. Subjects enrolled in the investigation already 6. Subjects included in other ongoing clinical investigation at present or during the past 30 days. Subjects participating in a clinical sample investigation might be enrolled in the investigation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>